Area of research
Genetics · Cellular and Molecular Neuroscience
Research interest
Research interests include Genetic Associations and Epidemiology, Genetics and Neurodevelopmental Disorders, Neurotransmitter Receptor Influence on Behavior, and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities.
Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies
Pharmacogenetics of antidepressant response: A polygenic approach
Interaction between the <i>FTO</i> gene, body mass index and depression: meta-analysis of 13701 individuals
New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation
Interaction between childhood maltreatment on immunogenetic risk in depression: Discovery and replication in clinical case-control samples
Genome-wide Association for Major Depression Through Age at Onset Stratification: Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium
Joint Analysis of Psychiatric Disorders Increases Accuracy of Risk Prediction for Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
Polygenic interactions with environmental adversity in the aetiology of major depressive disorder
Genetic Differences in the Immediate Transcriptome Response to Stress Predict Risk-Related Brain Function and Psychiatric Disorders
A genetic risk score combining 32 SNPs is associated with body mass index and improves obesity prediction in people with major depressive disorder
Exploring the role of drug-metabolising enzymes in antidepressant side effects
The correlation between reading and mathematics ability at age twelve has a substantial genetic component
Epigenomic and transcriptomic signatures of a Klinefelter syndrome (47,XXY) karyotype in the brain
A Genome Wide Association Study of Mathematical Ability Reveals an Association at Chromosome 3q29, a Locus Associated with Autism and Learning Difficulties: A Preliminary Study
Common Genetic Variation and Antidepressant Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Genome-Wide Pharmacogenetic Studies
Genetic differences in cytochrome P450 enzymes and antidepressant treatment response
Integrative Mouse and Human mRNA Studies Using WGCNA Nominates Novel Candidate Genes Involved in the Pathogenesis of Major Depressive Disorder
A mega-analysis of genome-wide association studies for major depressive disorder
Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline ‘Predictors’ and Longitudinal ‘Targets’
Genetic Predictors of Response to Serotonergic and Noradrenergic Antidepressants in Major Depressive Disorder: A Genome-Wide Analysis of Individual-Level Data and a Meta-Analysis
The current state of play on the molecular genetics of depression
Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response
Estimating the heritability of reporting stressful life events captured by common genetic variants
Interaction between specific forms of childhood maltreatment and the serotonin transporter gene (5-HTT) in recurrent depressive disorder
Dissecting the Genetic Heterogeneity of Depression Through Age at Onset
Meta-analyses of genome-wide linkage scans of anxiety-related phenotypes